glutamic acid has been researched along with Cranial Nerve II Injuries in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 11 (64.71) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Behnammanesh, G; Ji, D; Li, H; Majid, ASA; Rong, R; Wu, Z; You, M | 1 |
| Brown, AM; Chen, S; Evans, RD; Hamner, MA; Ransom, BR; Yang, X; Ye, ZC | 1 |
| Fukumoto, M; Horie, T; Ikeda, T; Kida, T; Kojima, S; Mimura, M; Morishita, S; Nishikawa, Y; Oku, H | 1 |
| Benhar, I; Kalchenko, V; Reemst, K; Schwartz, M | 1 |
| Fukuda, M; Kanamori, A; Naka, M; Nakamura, M; Negi, A | 1 |
| Charalambous, P; Schallenberg, M; Thanos, S | 1 |
| Chen, F; Huang, M; Jiang, F; Lei, H; Li, S; Wang, X | 1 |
| Behrens-Baumann, W; Dietzmann, K; Mawrin, C; Pallas, M; Pap, T; Vorwerk, CK | 1 |
| Dreyer, EB; Mawrin, C; McDermott, LM; Vorwerk, CK; Zurakowski, D | 1 |
| Avidan, H; Cardon, M; Kipnis, J; Lewitus, GM; Mordechay, S; Rolls, A; Schwartz, M; Shani, Y | 1 |
| Gersner, R; Hart, RP; Meiri, G; Mordechai, S; Schwartz, M; Shaked, I; Tchoresh, D; Xiao, X | 1 |
| Miki, A; Morimoto, T; Okada, M; Otori, Y; Tano, Y | 1 |
| Ahn, JH; Caprioli, J; Kim, SH; Kwong, JM; Munemasa, Y; Piri, N | 1 |
| Schwartz, M; Yoles, E | 1 |
| D'Anna, SA; Kerrigan, D; Kerrigan-Baumrind, LA; Levkovitch-Verbin, H; Pease, ME; Quigley, HA | 1 |
| Hauben, E; Kipnis, J; Schori, H; Schwartz, M; Shaked, I; Yoles, E | 1 |
| Fisher, J; Haggiag, S; Levkovitch-Verbin, H; Mizrahi, T; Revel, M; Schori, H; Schwartz, M; Yoles, E | 1 |
17 other study(ies) available for glutamic acid and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Topics: Animals; Antioxidants; Biological Products; Cell Survival; Crush Injuries; Cytokines; Disease Models, Animal; Echium; Ethanol; Glutamic Acid; Mice; Neuroprotective Agents; NF-kappa B; Optic Nerve; Optic Nerve Injuries; Plant Extracts; Rats; Reactive Oxygen Species; Retinal Ganglion Cells | 2022 |
Novel hypoglycemic injury mechanism: N-methyl-D-aspartate receptor-mediated white matter damage.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Brain; Calcium; Disease Models, Animal; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Glycogen; Hydrogen-Ion Concentration; Hypoglycemia; Kynurenic Acid; Lactic Acid; Leukoencephalopathies; Mice; Mice, Inbred C57BL; Optic Nerve Injuries; Quinoxalines; Receptors, N-Methyl-D-Aspartate | 2014 |
Negative impact of AQP-4 channel inhibition on survival of retinal ganglion cells and glutamate metabolism after crushing optic nerve.
Topics: Animals; Aquaporin 4; bcl-2-Associated X Protein; Cell Count; Cell Survival; Cells, Cultured; Disease Models, Animal; Ependymoglial Cells; Glutamic Acid; Immunoblotting; Male; Niacinamide; Optic Nerve; Optic Nerve Injuries; Rats; Rats, Transgenic; Rats, Wistar; Real-Time Polymerase Chain Reaction; Retinal Ganglion Cells; RNA; Thiadiazoles; Up-Regulation | 2016 |
The retinal pigment epithelium as a gateway for monocyte trafficking into the eye.
Topics: Animals; Autoimmune Diseases; Chemotaxis, Leukocyte; CX3C Chemokine Receptor 1; Gene Expression; Glutamic Acid; Green Fluorescent Proteins; Male; Mice, Inbred C57BL; Mice, Transgenic; Monocytes; Optic Nerve Injuries; Receptors, Cytokine; Receptors, HIV; Retinal Pigment Epithelium; Retinitis; Vascular Cell Adhesion Molecule-1 | 2016 |
Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo.
Topics: Animals; Antihypertensive Agents; Apoptosis; Calcium; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glutamic Acid; Intraocular Pressure; Latanoprost; Male; Neuroprotective Agents; Optic Nerve Injuries; Prostaglandins F, Synthetic; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Signal Transduction | 2009 |
GM-CSF regulates the ERK1/2 pathways and protects injured retinal ganglion cells from induced death.
Topics: Adult; Aged; Animals; Apoptosis; bcl-Associated Death Protein; Blotting, Western; Butadienes; Cells, Cultured; Disease Models, Animal; Glaucoma; Glutamic Acid; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxylamines; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neuroanatomical Tract-Tracing Techniques; Nitriles; Nitro Compounds; Optic Nerve Injuries; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Retinal Ganglion Cells; Staurosporine | 2009 |
Retinal metabolic changes in an experimental model of optic nerve transection by ex vivo 1H magnetic resonance spectroscopy.
Topics: Animals; Aspartic Acid; Axotomy; Creatine; Female; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Glutamic Acid; Magnetic Resonance Spectroscopy; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Taurine | 2011 |
Changes of retinal glutamate transporter GLT-1 mRNA levels following optic nerve damage.
Topics: Animals; Cell Death; DNA Primers; Down-Regulation; Excitatory Amino Acid Transporter 2; Glutamic Acid; Homeostasis; Models, Animal; Nerve Crush; Optic Nerve Injuries; Rats; Rats, Wistar; Retina; Retinal Ganglion Cells; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation | 2003 |
Effects of axonal injury on ganglion cell survival and glutamate homeostasis.
Topics: Animals; Axons; Cell Survival; Glutamic Acid; Homeostasis; Optic Nerve Injuries; Rats; Rats, Long-Evans; Retinal Ganglion Cells | 2004 |
Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Adhesion; Cell Movement; Cell Separation; Cell Survival; Cells, Cultured; Disease Models, Animal; Dopamine; Dopamine Agonists; Down-Regulation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Glutamic Acid; Immune Tolerance; Mice; Nerve Crush; Nerve Degeneration; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Receptors, Dopamine D1; Receptors, Dopamine D5; Receptors, Interleukin-2; Retinal Ganglion Cells; Signal Transduction | 2004 |
Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators.
Topics: Animals; Antibodies; Antigen-Presenting Cells; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Autoimmunity; Cells, Cultured; Cyclooxygenase 2; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flow Cytometry; Glial Fibrillary Acidic Protein; Glutamic Acid; Histocompatibility Antigens Class II; Immunohistochemistry; Interferon-gamma; Lipopolysaccharides; Microglia; Myelin Basic Protein; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligonucleotide Array Sequence Analysis; Optic Nerve Injuries; Oxidative Stress; Phagocytes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; STAT1 Transcription Factor; Time Factors; Trans-Activators | 2005 |
Protective effect of donepezil on retinal ganglion cells in vitro and in vivo.
Topics: Administration, Oral; Animals; Axotomy; Benzopyrans; Cell Survival; Cells, Cultured; Cholinergic Antagonists; Cholinesterase Inhibitors; Cytoprotection; Donepezil; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Glutamic Acid; Indans; Mecamylamine; Neuroprotective Agents; Nitriles; Optic Nerve Injuries; Piperidines; Rats; Retinal Ganglion Cells; Scopolamine | 2006 |
Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress.
Topics: Animals; Axotomy; Blotting, Western; Buthionine Sulfoximine; Cell Count; Cell Survival; Electroporation; Gene Expression Regulation; Glutamic Acid; Immunohistochemistry; Optic Nerve Injuries; Oxidative Stress; Rats; Rats, Wistar; Retinal Ganglion Cells; Thioredoxins; Transfection; Up-Regulation | 2008 |
Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve.
Topics: Animals; Aqueous Humor; Aspartic Acid; Cell Death; Chromatography, High Pressure Liquid; Glutamic Acid; Male; Nerve Crush; Nerve Degeneration; Nerve Fibers; Optic Nerve Diseases; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells | 1998 |
Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells.
Topics: Animals; Axons; Cell Count; Cell Death; Fluorescein Angiography; Glutamic Acid; Macaca fascicularis; Nerve Fibers; Optic Nerve; Optic Nerve Injuries; Retinal Degeneration; Retinal Ganglion Cells | 2001 |
Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response.
Topics: Animals; Autoimmunity; Cell Count; Cell Survival; Central Nervous System; Disease Models, Animal; Drug Administration Routes; Encephalomyelitis, Autoimmune, Experimental; Female; Genetic Predisposition to Disease; Glutamic Acid; Immunity, Cellular; Injections; Male; Mice; Mice, Inbred Strains; Mice, Nude; Nerve Crush; Neurons; Optic Nerve Injuries; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Sprague-Dawley; Retinal Ganglion Cells; Species Specificity; Spinal Cord Injuries; T-Lymphocytes; Wounds, Nonpenetrating | 2001 |
Increased post-traumatic survival of neurons in IL-6-knockout mice on a background of EAE susceptibility.
Topics: Animals; Cell Survival; Drug Resistance; Encephalomyelitis, Autoimmune, Experimental; Female; Genetic Predisposition to Disease; Glutamic Acid; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Crush; Nerve Degeneration; Neurons; Optic Nerve Injuries; Retinal Ganglion Cells | 2001 |